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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Staphylococcus lugdunensis is a coagulase-negative staphylococcus that
cannot be ignored. This study is a comprehensive analysis of the clinical and microbiological
characteristics of S. lugdunensis bacteremia and sterile site infection during hospitalization.
Methods: This retrospective study included 48 patients with invasive S. lugdunensis infection.
During the period of March 2002 to July 2012, they had been hospitalized in a tertiary center of
northern Taiwan. Demographics, clinical characteristics, and risk factors of mortality were
analyzed. All isolates were tested for antimicrobial susceptibility. We identified the staphylo-
coccal cassette chromosome mec (SCCmec) gene for oxacillin nonsusceptible isolates.
Results: The incidence of S. lugdunensis in coagulase-negative staphylococci bacteremia was
0.87%. Forty-eight patients were enrolled: S. lugdunensis was present in 41 patients with
bacteremia, in the ascites of three patients, in the synovial fluid of two patients, in the pleural
effusion of one patient, and in the amniotic fluid of one patient. The three most common
sources of infection were primary bacteremia (43.8%), catheter-related infection (18.8%),
and vascular graft infection (12.5%). All-cause mortality during hospitalization was 20.8%
(10/48). All deceased patients were bacteremic. Risk factors associated with in-hospital mor-
tality included a Pittsburgh bacteremia score of 2 or greater, infective endocarditis, and end-of Laboratory Medicine, Chang Gung Memorial Hospital at Linkou, Number 5, Fu-Shin Street, Gueishan
m (J.-J. Lu).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
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Invasive Staphylococcus lugdunensis infection 407stage renal disease. Ten (20.8%) isolates were resistant to oxacillin, and 8 isolates were clas-
sified as SCCmec type V.
Conclusion: The clinical significance of S. lugdunensis should not be ignored, especially in pa-
tients with severe comorbidities. An aggressive search for endocarditis is strongly suggested in
S. lugdunensis bacteremic cases.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Staphylococcus lugdunensis, which was named after the
city where the organism was initially isolated, is a species
of coagulase-negative staphylococci (CoNS). Since its first
description in 1988 by Freney et al,1 this organism has been
considered a human pathogen that cannot be ignored.2 In
contrast to other CoNS, the behavior of S. lugdunensis is
more like that of Staphylococcus aureus.2 S. lugdunensis
causes a wide spectrum of infections such as skin and soft
tissue infection, bone and joint infection, meningitis,
catheter-related infection, bacteremia, and infective
endocarditis.2 The most common sites are skin and soft
tissue.3,4 However, most articles have focused on S. lug-
dunensis-related bacteremia and infective endocarditis.5e7
Some studies on CoNS-related bacteremia have demon-
strated that the most common pathogen is Staphylococcus
epidermidis (incidence rate ranges from 35% to 67.6%),
followed by Staphylococcus haemolyticus and Staphylo-
coccus hominis.8,9 The mortality rate of patients with CoNS
bacteremia ranges from 8% to 14.3%.8,9 There is no statis-
tical significance in mortality between species. S. lugdu-
nensis was not particularly identified in these studies,
probably because it constitutes a very small proportion of
CoNS.10 The mortality rate of patients with S. lugdunensis
bacteremia varies in relation to the presence of infective
endocarditis.11 The mortality rate associated with S. lug-
dunensis endocarditis is reportedly higher than that of S.
aureus and S. epidermidis.2
There are limited articles that discuss S. lugdunensis in
Asia.4,11e14 In these articles, there are some discrepancies
between the infectious origin (i.e., the setting of the ac-
quired infection), involved infectious foci, and antimicro-
bial susceptibility. In Taiwan, only one study issued the
characteristics of community-acquired S. lugdunensis
infection, whereas a few cases described in other series
have focused on infective endocarditis.5,13,15 Furthermore,
only a few studies mention the prevalence and genotypes of
oxacillin-resistant S. lugdunensis.4,16,17
We designed this retrospective study to investigate the
clinical characteristics and risk factors of mortality of S.
lugdunensis bacteremia and sterile site infection. All iso-
lates underwent antimicrobial susceptibility testing. In
methicillin-resistant S. aureus (MRSA), most health care-
associated or nosocomial clones are associated with
staphylococcal cassette chromosome mec (SCCmec) type II
or type III, and most community-associated MRSA (CA-
MRSA) strains are associated with SCCmec type IV.18 S.
lugdunensis is short of relevant information. Therefore, we
performed SCCmec gene classification for the oxacillin-
resistant isolates in our study.Materials and methods
Setting
This retrospective study was conducted at Chang Gung
Memorial Hospital at Linkou (CGMH-Linkou; Taoyuan,
Taiwan), a 3715-bed tertiary center in northern Taiwan. It
was approved by the research ethics committee (i.e.,
institutional research board) of CGMH-Linkou (101-4429B).
Study design and patients
Between March 2002 and July 2012, 88 S. lugdunensis iso-
lates from sterile sites (e.g., blood, ascites, pleural effu-
sion, synovial fluid, amniotic fluid) were identified through
our computer-assisted microbiology laboratory database.
Isolates collected from postsurgical drainage tubes were
excluded because of the high probability of contamination.
S. lugdunensis isolated from two or more consecutive
blood cultures or sterile body fluids of patients were
considered clinically significant cases. For patients with a
single positive blood culture of S. lugdunensis, the clinical
significance was determined in accordance with the criteria
developed in 1998 by Souvenir et al.19 Patients were
considered to have a clinically significant case if they had
one or more of the following: prolonged fever with a tem-
perature of 38C or greater; hypotension with a systolic
blood pressure less than 90 mmHg; leukocytosis or leuko-
penia with a left-shifted differential; or disseminated
intravascular coagulopathy in combination with a major risk
factor for potential infection caused by skin flora (including
longterm intravascular catheterization used for hospital-
ized patients, immunosuppressed patients with central
lines, patients with peritoneal dialysis or hemodialysis, and
other patient populations). Chart review was used to
collect data such as demographics, comorbidities, origin of
infection, source of infection, illness severity, indications
for admission to intensive care units, and outcomes.
Definitions
The Pittsburgh bacteremia score and severe sepsis (defined
by surviving sepsis campaign20) were used to assess acute
illness severity. Acute kidney injury was reflected by an
increase in the serum creatinine (SCr) level by at least
0.3 mg/dL (26.5 mmol/L) within 48 hours; as an increase in
the SCr level to at least 1.5 times the baseline level, which
is known or presumed to have occurred within the previous
7 days; or as a urine volume less than 0.5 mL/kg/h for 6
hours.21 The origin of infection was defined as: (1)
Table 1 Demographic characteristics of 48 patients with
clinically significant Staphylococcus lugdunensis infection
Characteristics Value
Age (y) 60.238  21.53
Male 23 (47.9)
Comorbid illness
Hypertension 21 (43.8)
End-stage renal disease 20 (41.7)
Diabetes mellitus 16 (33.3)
Cerebrovascular disease 13 (27.1)
Malignancy 13 (27.1)
Liver cirrhosis 6 (12.5)
Clinical and Laboratory data
Bacteremia 41 (85.4)
Polymicrobial infection 9 (18.8)
Fever 39 (81.3)
Leukocytosis or leukopeniaa 21 (44.7)
Anemiab 38 (80.9)
Thrombocytopeniac 17 (37)
Acute kidney injuryd 4 (14.8)
Pittsburgh bacteremia score 1.59  3.008
Pittsburgh bacteremia score S 2 12 (29.3)
Severe sepsis 15 (31.3)
ICU required 7 (14.6)
Origin of infection
Community-acquired 5 (10.4)
Health care-associated 18 (37.5)
Hospital-acquired 25 (52.1)
Source of infection
Primary bacteremia 21 (43.8)
Catheter-related infection 9 (18.8)
Vascular graft infection 6 (12.5)
Infective endocarditis 4 (8.3)
Bone and joint infection 4 (8.3)
Intra-abdominal infection 2 (4.2)
Skin and soft tissue infection 1 (2.1)
Pelvic infection 1 (2.1)
Adequate treatment 33 (68.8)
Mortality during hospitalization 10 (20.8)
a One patient had no leukocyte count data.
b One patient had no hemoglobin data.
c Two patients had no platelet data.
d Twenty patients had end-stage renal disease, and one pa-
tient had no creatinine data within 48 hours of infection onset.
Data are presented as n (%) or mean  standard deviation.
ICU Z intensive care unit.
408 J.-F. Lin et al.community-acquired (i.e., infection onset less than 48
hours prior to admission); (2) health care-associated
(including a history of hospitalization or surgery in the
previous 3 months, residence in a nursing home, chronic
dialysis); or (3) hospital-acquired (i.e., infection onset is 48
or more hours after admission). The source of infection was
determined by medical records, culture sites, and clinical
physician’s judgment. The diagnosis of infective endo-
carditis was based on the modified Duke criteria.22
Adequate treatment was defined as the use of at least
one effective antimicrobial agent, based on susceptibility
results within 48 hours of infection onset.
Microbiological tests
The BACTEC 9240 system (Becton, Dickinson and Company,
Madison, WI, USA) was used for processing blood cultures,
ascites, and synovial fluid. Other sterile body fluids were
processed by the conventional method. Isolates were identi-
fied as S. lugdunensis, according to the following properties:
aerobic, Gram-positive cocci in clusters on a Gram’s stain;
catalase-positive; coagulase-negative; pyrrolidonyl arylami-
dase test (PYR test)-positive; and the presence of ornithine
decarboxylase activity.23 Polymerase chain reaction (PCR)24
and the Bruker Biotyper (database 2.0) matrix-assisted laser
desorption ionization/time of flight mass spectrometry
(MALDI-TOF MS) method25 were used for the second and third
reconfirmation tests, respectively. Oxacillin minimal inhibi-
tory concentration (MIC) was performed by using the agar
dilution method, based on the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.26 The susceptibility data of
other antimicrobials (clindamycin, erythromycin, etc.) were
tested by the CLSI disc diffusion method.26 Staphylococcal
cassette chromosome mec gene detection was executed by
the combination of multiplex PCRs.27
Statistical analysis
Categorical variables were compared by using the Fisher’s
exact test or Chi-square test, as appropriate. Continuous
variables were compared by using the Mann-Whitney U test.
Multivariate analysis was performed by logistic regression
with forward LR model to adjust for confounding. All vari-
ables with a p < 0.20 on univariate analysis were included
in the multivariate model. A two-tailed p < 0.05 on multi-
variate analysis was considered statistically significant. All
statistical calculations were performed by SPSS version 18.0
software (SPSS Inc., Chicago, IL, USA).
Results
During the study period, 88 S. lugdunensis strains were
isolated from blood (n Z 81) or sterile site fluids (n Z 7).
Forty-eight (54.5%) isolates were clinically significant in-
fections. There were 41 patients with bacteremia. The
other seven nonbacteremic patients had S. lugdunensis
isolated from ascites in three patients, synovial fluid in
two patients, pleural effusion in one patient, and amni-
otic fluid in one patient. Table 1 shows the patients’ de-
mographics data and clinical characteristics. The three
most common comorbidities were hypertension, end-stage renal disease (ESRD), and diabetes mellitus. Nine
patients had polymicrobial infections; concomitant non-S.
lugdunensis isolates were obtained from the blood of
seven patients, from the pleural effusion of one patient,
and from the amniotic fluid of one patient. Thirty-nine
(81.3%) of the 48 patients had fever, and 21 (44.7%) pa-
tients had leukocytosis or leukopenia. The Pittsburgh
bacteremia scores were two points or more in 12 (29.3%)
patients with bacteremia. Fifteen (31%) patients had se-
vere sepsis.
The origin of only five (10.4%) infections could be
defined as community-acquired. The proportions of health
Table 2 Comparison of antimicrobial resistance between five community-acquired infections and 43 health care-associated
and hospital-acquired infections
Overall Community-acquired
infection
Health care-associated or
hospital-acquired infection
p
Clindamycin 9 (18.8) 1 (20) 8 (18.6) 1.000
Erythromycin 12 (25) 2 (40) 10 (23.3) 0.587
Oxacillin 10 (20.8) 0 10 (23.2) 0.569
Penicillin 33 (68.8) 2 (40) 31 (72.1) 0.307
Trimethoprim-sulfamethoxazole 1 (2.1) 1 (20) 0 0.104
Vancomycin 0 0 0
Teicoplanin 0 0 0
Data are presented as n (%).
Table 3 General data and staphylococcal cassette chromosome mec typing of 10 oxacillin-resistant Staphylococcus ludgu-
nensis isolates
Sex, age (y) Year of
isolation
Acquisition Source of infection M1
type
M2 type mecA SCCmec
type
M, 43 2009 Health care- associated Vascular graft infection 5 C þ V
M, 71 2009 Hospital-acquired Primary bacteremia 5 C þ V
F, 93 2010 Health care- associated Catheter-related infection 2 A þ Untypable
M, 63 2010 Health care- associated Primary bacteremia 5 C þ V
F, 55 2010 Hospital-acquired Primary bacteremia 2 A þ II
F, 47a 2010 Hospital-acquired Catheter-related infection 5 C þ V
M, 2 mo 2011 Hospital-acquired Catheter-related infection 5 C þ V
F, 3 mo 2011 Hospital-acquired Primary bacteremia 5 C þ V
M, 81 2011 Hospital-acquired Primary bacteremia 5 C þ V
F, 66 2012 Hospital-acquired Primary bacteremia 5 C þ V
a Isolated from ascites; other strains were isolated from blood.
F Z female; M Z male; SCCmec Z staphylococcal cassette chromosome mec.
Invasive Staphylococcus lugdunensis infection 409care-associated and hospital-acquired infection were
37.5% (n Z 18) and 52.1% (n Z 25), respectively. The in-
fectious sources could be identified in 56.3% of patients
[catheter-related infection, 18.8% (n Z 9); vascular graft
infection, 12.5% (n Z 6); infective endocarditis, 8.3%
(n Z 4); bone and joint infection, 8.3% (n Z 4); intra-Table 4 Univariate analysis of risk factors for mortality in pati
Survival (n Z
Age (y) 58.855  24
Sex
Male 16 (51.6)
Laboratory data
Polymicrobial bacteremia 7 (22.6)
Leukocytosis or leukopenia 12 (38.7)
Anemia 23 (76.7)a
Thrombocytopenia 9 (30)b
Acute kidney injury 2 (10)c
Pittsburgh bacteremia score S 2 6 (19.4)
Comorbid illness
Hypertension 13 (41.9)
Diabetes mellitus 10 (32.3)
End-stage renal disease 11 (35.5)
Liver cirrhosis 4 (12.9)
Cerebrovascular disease 8 (25.8)
Malignancy 9 (29)abdominal infection, 4.2% (n Z 2); skin and soft tissue
infection, 2.1% (n Z 1); and pelvic infection, 2.1%
(n Z 1)]. The all-cause mortality during hospitalization
was 20.8% (n Z 10).
All 48 isolates were susceptible to vancomycin and tei-
coplanin (Table 2). Approximately nine (19%) isolates wereents with bacteremia
31) Mortality (n Z 10) Univariate analysis (p)
.07 66.86  15.55 0.233
3 (30) 0.292
0 0.164
4 (40) 1.000
10 (100) 0.161
6 (60) 0.135
1 (50)d 0.260
6 (60) 0.040
5 (50) 0.724
4 (40) 0.712
8 (80) 0.026
1 (10) 1.000
5 (50) 0.241
1 (10) 0.402
Table 4 (continued )
Survival (n Z 31) Mortality (n Z 10) Univariate analysis (p)
Site of acquisition
Community-acquired 3 (9.7) 2 (20) 0.580
Health care-associated 10 (32.3) 5 (50) 0.453
Hospital-acquired 18 (58.1) 3 (30) 0.159
Health care-associated or hospital-acquired 28 (90.3) 8 (80) 0.580
Primary site of infection
Infective endocarditis 1 (3.2) 3 (30) 0.039
Catheter-related infection 5 (16.1) 0 (0) 0.172
Vascular graft infection 5 (16.1) 1 (10) 1.000
Primary bacteremia 15 (48.4) 6 (60) 0.719
Bone and joint infection 2 (6.5) 0 0.566
Skin and soft tissue infection 1 (3.2) 0 1.000
Intra-abdominal infection 2 (6.5) 0 1.000
ICU required 3 (9.7) 3 (30) 0.143
Adequate antibiotics 21 (67.7) 7 (70) 1.000
a One patient had no hemoglobin data.
b One patient had no platelet data.
c Eleven patients had end-stage renal disease.
d Eight patients had end-stage renal disease.
Data are presented as n (%) or mean  standard deviation.
ICU Z intensive care unit.
410 J.-F. Lin et al.resistant to clindamycin, whereas 12 (25%) isolates were
resistant to erythromycin. Ten (20.8%) isolates were resis-
tant to oxacillin and 33 (68.8%) isolates were resistant to
penicillin. Only one isolate was not susceptible to
trimethoprim/sulfamethoxazole. All 10 oxacillin-resistant
strains were health care-associated or hospital-acquired
infections. There was no statistically significant differ-
ence in antimicrobial susceptibility between isolates from
community-acquired infection and health care-associated
infection. The oxacillin-resistant strains all carried the
mecA gene, and eight (80%) of 10 strains were SCCmec type
V. The SCCmec typing in these strains are listed in Table 3.
Tables 4 and 5 summarize the risk factors associated
with in-hospital mortality in patients with bacteremia. In
univariate analysis, a Pittsburgh bacteremia score of 2 or
greater, infective endocarditis, and ESRD were associated
with all-cause mortality during hospitalization. A similar
result occurred with multivariate analysis.Discussion
To date, articles on clinically significant S. lugdunensis
infection report a limited number of cases.6,11,28 Our study
examined the largest number of S. lugdunensis infection
cases, which were mostly bacteremia cases. Since May
2009, S. lugdunensis has routinely been identified in blood
specimens in our hospital. Between May 2009 and July 2012,
the incidence of S. lugdunensis in CoNS bacteremia was
0.87% (67/7673 cases). This was compatible with the find-
ings of a study in Korea that reported an incidence of
0.9%.11 However, it was much higher than the incidence of
0.3% reported in a study in the United States.10
S. lugdunensis is traditionally identified via the
biochemical methods mentioned previously, which are
time-consuming and can have false interpretations becauseof artificial mistakes such as mixed cultures, contaminated
mineral oil used in the ornithine decarboxylase test, and
the interpretation of weak positive findings in ornithine
decarboxylase activity test. Polymerase chain reaction of-
fers a faster and more accurate method for identifying
bacteria strains, which can facilitate appropriate therapy.
In our study, 58 patients were originally believed to have
invasive S. lugdunensis infections, but PCR identified other
CoNS in 10 patients (data not shown). In addition, we used a
MALDI-TOF MS method as the third confirmation test for S.
lugdunensis identification. The result excellently corre-
lated with PCR. Since 2007, the identification of bacteria
species by the MALDI-TOF MS method has been reported,
and several articles involve S. lugdunensis identifica-
tion.29,30 These studies demonstrate that MALDI-TOF MS is a
reliable and rapid method for identifying staphylococci.
Most patients in our study had health care-acquired or
hospital-acquired infections. Community-acquired infec-
tion affected only five (10.4%) patients, which was lower
than in a previously reported study.11 In cases of health
care-associated and hospital-acquired infections, 19
(44.2%) of 43 patients had ESRD that required hemodialysis
or peritoneal dialysis. Because S. lugdunensis is a skin
commensal,2 patients undergoing frequent invasive pro-
cedures may have a higher risk of infection. The other three
most common comorbidities in our patients were hyper-
tension, diabetes mellitus, and cerebrovascular disease. All
three comorbidities may cause patients to require frequent
hospitalizations or longterm care.
Four (9.8%) of 41 bacteremic patients were diagnosed as
having infective endocarditis (IE). One patient had
pacemaker-associated IE, which has been rarely reported in
previous studies.2,31 All four patientswerenative valve IE, and
threeof thesepatients had left-sidedvalve involvement. All IE
patients received surgery, and the mortality was relatively
high (75%) in our study. A previous article5 described the
Table 5 Multivariate analysis of risk factors for all-cause
mortality in patients with bacteremia
OR (95% CI) p
Pittsburgh
bacteremia
score S 2
55.464 (3.096e993.596) 0.006
Infective
endocarditis
293.497 (4.939e17439.534) 0.006
End-stage
renal disease
27.025 (1.572e464.454) 0.023
CI Z confidence interval; OR Z odds ratio.
Invasive Staphylococcus lugdunensis infection 411characteristics of S. lugdunensis-related endocarditis, which
were of community-acquired origin, predominantly affects
left-sided valves, susceptible to penicillin, patients required
surgery, and most patients have native-valve involvement.
Our IEpatientsmatchedmostof these characteristics, buthad
a higher mortality rate (75% vs. 38.8%). Some studies have
mentioned possible IE-related virulence proteins such as
fibrinogen-binding protein and von Willebrand factor binding
protein2,32,33; however, these data are fragmentary and
scarce. A search for the integration of virulence factors in IE-
related strains may be needed.
S. lugdunensis infections, other than bacteremia, were
primarily catheter-associated. Three patients had continuous
ambulatory peritoneal dialysis tube-associated peritonitis,
and one patient had chest tube drainage-related empyema.
There were also two cases of septic knee arthritis, which has
been rarely reported in previous studies.2
There was one case of pelvic infection, which was
diagnosed as chorioamnionitis. The patient was a 34-year-
old female who was admitted because of high fever. Just 2
weeks prior to admission, she received McDonald’s sutures.
The specimen was obtained via amniocentesis. The culture
was polymicrobial. Other microorganisms included group B
Streptococcus and Peptostreptococcus. The patient under-
went an abortion because of unstable hemodynamics. Her
condition improved dramatically after the abortion. There
are few studies reporting amniotic fluid infection related to
S. lugdunensis.34 The role of this organism in cho-
rioamnionitis and septic abortion remains undefined.
The crude mortality of our patients was 20.8% (n Z 10),
and all of these patients had bacteremia. In previous
studies, the mortality rate of S. lugdunensis bacteremia
ranged from 0% to 23%.6,11,35 A Pittsburgh bacteremia score
of 2 or greater, ESRD, and IE were independently associated
with mortality in all patients with bacteremia. Severe un-
derlying diseases that may be responsible for mortality in
most conditions have been described in a previous study.11
The resistant rate of S. lugdunensis to oxacillin and
penicillin varies widely in published studies.2e4,6,10,11,36 In
most studies,3,4,6,36 oxacillin resistance was low (at most
5%). Our study showed a higher oxacillin resistance rate
(20.8%), which was similar to the rate in the Korean study.11
In most studies,3,4,6 the origin of infection was primarily by
community acquisition. However, all oxacillin-resistant
strains in our study were health care-associated or
hospital-acquired infections, which was similar to the
finding of the Korean study.11 Antibiotic use and invasive
procedures in noncommunity-acquired infections mayexplain this situation. Prior to 2005, different breakpoints
were used for the oxacillin minimal inhibitory concentra-
tion (MIC) of S. lugdunensis.2,37 Since 2005, the CLSI revised
the oxacillin breakpoints of S. lugdunensis as those estab-
lished for S. aureus (MIC of 2 mg/mL or less, categorized as
“susceptible”; MIC of 4 mg/mL or greater, categorized as
“resistant”).2,37e39 This may also cause the different result
in oxacillin susceptibility.
A few studies report the presence of SCCmec genes in
oxacillin-resistant strains of S. lugdunensis.3,4,12,16 Howev-
er, the number of resistant strains is small (ranging from 1
strain to 3 strains). In our study, all 10 oxacillin-resistant S.
lugdunensis isolates carried the SCCmecA gene. Eight iso-
lates were classified as SCCmec type V, one isolate was
classified as SCCmec type II, and one isolate could not be
classified. In Taiwan, SCCmec type V was found primarily in
community-acquired S. aureus, especially in subtype VT.
40
The difference between S. lugdunensis and S. aureus in
the SCCmec type V gene may need to be explored.
There are some limitations in this study. S. lugdunensis is
an uncommon pathogen, and the number of cases may still
be insufficient to demonstrate fully the clinical character-
istics. There is no accurate definition for the clinical sig-
nificance of a single blood culture positive for CoNS. This
may have added bias in the case collection.
S. lugdunensis accounts for only a small proportion of
CoNS bacteremia; however, its clinical significance should
not be ignoreddespecially in patients with severe comor-
bidities. The clinical spectrum of S. lugdunensis infections
varies widely. An aggressive search for the possibility of
infective endocarditis is strongly indicated among patients
with S. lugdunensis bacteremia.
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